Trial intelligence / Profile preview

MRC-5 Cell Rabies Vaccine 4-dose vs 5-dose Regimens vs HDCV

CTR20181701Phase 3Completed

Sponsor
Anhui Zhifei Longcom Biopharmaceutical
Start
Sep 2019
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of Rabies vaccine in rabies, sponsored by Anhui Zhifei Longcom Biopharmaceutical. Started Sep 2019; status: completed.

02

Drugs

Rabies vaccine
03

Conditions

rabies

Beyond the preview

Go deeper on CTR20181701.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20181701.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call